Opus Point Partners Management’s bluebird bio BLUE Stock Holding History

Opus Point Partners Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-451	Closed	-$743K	–	58
2019 Q2	$743K	Hold	451	–	–	1.1%	21
2019 Q1	$919K	Buy	451 +240	+114%	+$423K	1.25%	16
2018 Q4	$271K	Buy	211 +61	+41%	+$93.6K	0.6%	30
2018 Q3	$284K	Buy	150 +24	+19%	+$49.6K	0.68%	43
2018 Q2	$256K	Buy	126 +24	+24%	+$54.7K	0.56%	43
2018 Q1	$226K	Buy	+102	New	+$259K	0.44%	47
2015 Q2	–	Sell	-463	Closed	-$725K	–	60
2015 Q1	$725K	Buy	+463	New	+$611K	0.61%	45

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Opus Point Partners Management's BLUE Position: Q3 2019 in Review

Opus Point Partners Management sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 451 shares — an estimated $743K sold.

Opus Point Partners Management first reported a position in BLUE in Q1 2015 and held it in 7 quarters. The position peaked at $919K in Q1 2019. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

Opus Point Partners Management reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
Opus Point Partners Management sold 451 bluebird bio shares in Q3 2019, an estimated $743K.
Opus Point Partners Management first reported a position in bluebird bio in Q1 2015 and held it in 7 quarters.
Opus Point Partners Management's bluebird bio position peaked at $919K in Q1 2019.
241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.